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HIP1 crystal structures solved in our laboratory revealed abnormalities in the coiled-coil region,
suggesting intrinsic plasticity. To test this, speciﬁc amino acids in the coiled-coil were mutated.
The apparent thermal stability of HIP1 was altered when Thr528 and Glu531 were replaced by leu-
cine, and was enhanced when Lys510 was also mutated. In cells, HIP1 mutant expression produced
aggregation. MTS and ﬂow cytometry indicate a correlation between aggregated HIP1 and enhanced
cell death. These data support the idea that ﬂexibility of the HIP1 coiled-coil domain is important for
normal function and may lead to new insights into Huntington’s disease.
Structured summary of protein interactions:
HIP1 physically interacts with 23QHtt by anti tag coimmunoprecipitation (View interaction.)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Huntingtin interacting protein 1 (HIP1) was ﬁrst identiﬁed as an
obligate binding partner of huntingtin (htt) [1,2]. The expansion of
the polyglutamine (polyQ) tract of htt in the genetic neurodegener-
ative disorder, Huntington’s disease, severely weakens the interac-
tion between htt and HIP1 [1,2]. HIP1 is a member of a family of
coiled-coil proteins involved in clathrin-mediated endocytosis,
including HIP1R (HIP1-related) and the yeast homolog Sla2p. The
HIP family proteins share a domain structure that is divided into
an N-terminal ANTH/ENTH domain, a central coiled-coil (CC)
domain, and a C-terminal actin-binding (THATCH) domain [3].
The packing of heptad a- and d-positions in CCs are well deﬁned
(a-a0/d-d0 (parallel) or a-d0/d-a0 (antiparallel) [4]). Residues at the
a-position are frequently leucine, isoleucine or alanine and the
d-position is usually leucine or alanine [4,5]. Crystal structures
from our laboratory reveal the CC region of a HIP1 sub-fragment
is splayed opened, suggesting this coiled-coil region is plastic
[6–8]. The HIP1 parallel CC has a number of a- and d-residues that
are polar or charged. Previously, our laboratory argued the HIP1 CC
was destabilized by the atypical interface between coils [7,8].
Understanding the unusual interface may provide new insights
into why the polyQ expansion in mutated htt strongly compro-
mises the htt/HIP1 complex. To test if charged or polar residues
in the hydrophobic interface actually had an impact on the overallchemical Societies. Published by E
r and Cellular Biochemistry,
47405 United States.stability of the HIP1 CC, we mutated charged and polar residues in
the opened region to leucine. Here we report that replacing threo-
nine-528, glutamine-531 and lysine-510 with leucine alters the
apparent thermal stability of the HIP1 coiled-coil domain. Confocal
experiments show cells expressing HIP1 mutants contain aggre-
gates that are detectable as early as 6 h post-transfection. The
formation of HIP1 aggregations is correlated to loss of cell viability.
Based on these data we conclude that the opened region of HIP1
coiled-coil domain is sensitive to mutation, suggesting the intrinsic
plasticity of the CC is relevant for activity.2. Materials and methods
2.1. Site-directed mutagenesis
Single, double and triple mutations were created by site-
directed mutagenesis on pGEX2T1-HIP1h (aa373-647), pGEX2T-
HIP1482-586, pCDNA3.1-HIP1 full length or pEGFP-C2 HIP1 full
length. Primers used: T528L and Q531L 50 AGGGCCAGCGGAAG
CTTCAAGAACTTCTGGAAGTTCTAGAGAGC 30 and K510L 50 TAGAT
TTGGAACGAGAGCTTAAAGAGCTGGAGGATTCG 30 N489L: 50 TGACC
TGCTGCGGAAGCTTGCAGAGGTGACCAAACAGG 30. All sequences
were conﬁrmed before use.
2.2. Circular dichroism
CD measurements were performed on 0.2 mg/ml HIP1h 373-
647 (WT and mutations puriﬁed as in [7,8]) in 10 mM potassiumlsevier B.V. All rights reserved.
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concentration was determined using Bradford reagent. Spectra
were collected on samples from 300 to 190 nm at 5 C temperature
increments from 5 C to 80 C. Experiments were performed in
triplicate on three independent protein preparations. K2D2 was
used for secondary structure analysis [9].
2.3. Dynamic light scattering measurements
HIP1 468-547 WT and mutants (0.1 mg/ml) in 10 mM Mes pH
6.0, 50 mM NaCl were measured on a Malvern Zetasizer Nano-S.
Experiments were performed on three independent protein prepa-
rations in triplicate.
2.4. Cell culture and transfections
All cells were maintained at 37 C in 5% CO2. HEK293T cells
were cultured in 90% DMEM (Gibco), 10% FBS (Sigma–Aldrich)
and 100 U/ml penicillin/100 lg/ml streptomycin (Gibco). SH-SY5Y
cells were cultured in 90% DMEM/F12 (Gibco), 10% FBS and penicil-
lin/streptomycin. N2a cells were maintained in MEM (Gibco), 10%
FBS, penicillin/streptomycin, and 2 mM GlutaMAX I (Gibco).
Transient transfections were performed in all cell lines with
FugeneHD (Roche) or TransIT2020 (Mirus). Transfection complexes
were added to cells directly after plating to and incubated for
6–48 h.
2.5. Confocal microscopy
Cells were plated onto poly-l-lysine coated coverslips and trans-
fected with pEGFP-HIP1 full length (FL) WT and mutant constructs
or pcDNA3.1-HIP1(FL)WT or 2M + K510L. Cells were ﬁxed, perme-
abilized, and nuclei were stained with Draq5 (Cell Signal Technol-
ogies) andmounted using ProLong Gold (Life Technologies). For the
untagged constructs, cells were incubated with anti-HIP1 (Novus
Biologicals) and AlexaFluor-488 (Life Technologies) antibodies.
Microscopy was performed on a Leica Sp5 scanning confocal
microscope. Minimum of 75 cells per treatment over 5 indepen-
dent experiments were analyzed.
2.6. MTS assays
Cells were plated in 96 well plates, transfected, and MTS assays
(Promega) performed at 18, 24 and 48 h post-transfection. Experi-
ments are minimum of six independent repeats per time point.
2.7. Flow cytometry
HEK293T cells were transfected for 18 h, trypsinized and col-
lected by centrifugation. Cells were then washed in PBS and resus-
pended in 10 mM HEPES pH 7.4, 140 mM NaCl, 2.5 mM CaCl2. Cells
were labeled with AlexaFluor-647-conjugated AnnexinV and SyTox
AADvantage (Life Technologies), a 7AAD ﬂuorophore. Cells were
analyzed on a BD Biosciences LSRII ﬂow cytometer. Gates were
established for GFP-expressing cells only. Data were collected for
six independent repeats.
2.8. Coimmunoprecipitation and Western blotting
HEK293T cells were co-transfected pcDNA3.1-23Qhtt-myc/
pEGFP-HIP1(FL) WT or mutant constructs for 24 h. Cells were
rinsed in PBS, then scraped in cold co-IP buffer (50 mM Tris–HCl,
pH 7.5, 15 mM EDTA, 100 mM NaCl, 0.2% (v/v) Triton X-100, cOm-
plete protease inhibitor cocktail (Roche)) and centrifuged. Super-
natants were precipitated with Dynabeads ProteinA (Life
Technologies) charged with anti-GFP antibody (ab290, Abcam).Complexes were washed with co-IP buffer before elution by boiling
in 1X SDS-buffer. Samples were run on 10% SDS–PAGE gels, trans-
ferred to PVDF (Millipore), probed with anti-HIP1 and anti c-myc
(Novus Biologicals) primary antibodies and detected by chemilu-
minescence (ThermoFisher). Blots are representative of ﬁve inde-
pendent repeats.
2.9. Statistics
Students t test or one way ANOVA tests were used to determine
signiﬁcance at 95% or greater conﬁdence.3. Results and discussion
3.1. Replacement of charged residues at a- and d-positions stabilizes
the HIP1 coiled-coil
In this report HIP1 constructs with both T528L and Q531L are
2M, while HIP1 constructs that also include the K510L are desig-
nated 2M + K510L (Fig. 1A). To assess if the mutations impacted
secondary structure or global stability of HIP1, far-UV CD data on
HIP1h (aa 371-647) WT, K510L, 2M and 2M + K510L were acquired
at different temperatures and compared (Fig. 1B–E). We analyzed
the spectra from 240–190 nm to determine secondary structure
content [9]. As the sample was heated, the characteristic helical
CD proﬁle (double minimum at 208, 222 nm and a peak
190 nm) was transformed (Fig. 1B–E). All four proteins had
reversible melting curves (data not shown). We found that the
mutations did not change the overall helical content, but altered
the sensitivity of the structure to temperature. For WT and the sin-
gle point mutation K510L, this sensitivity occurred around 40 C. In
contrast, the helical content of the double and triple mutations be-
gan to decrease at around 50 C and 60 C, respectively (see Sup-
plementary Table 1). The 222 nm data plotted against
temperature show mutations in HIP1h cause non-ideal features
in the melting curves (Fig. 1F). We also observed that 80 C is not
sufﬁcient to completely melt out secondary structure as we would
expect the signal at 222 nm to be positive for aperiodic structure.
To address the possibility that high temperature triggered dynamic
protein aggregation, we monitored urea-induced unfolding at
222 nm. We ﬁnd that HIP1h WT and the single point mutation
K510L had a similar transition midpoint at 2M urea (data not
shown). On the other hand, HIP1h 2M and 3M both had transition
midpoints around 3.4 M urea. This suggests the double and triple
mutation conferred more resistance to urea-induced unfolding
than either WT or the single mutation K510L. Together, the CD data
indicate secondary structure stability is enhanced when the
charged or polar residues are removed from the speciﬁc locations
within the CC interface.
3.2. Overexpression of full-length HIP1 mutants causes aggregation
that increases htt immunoprecipitation
To investigate if the K510L, 2M, and 2M + K510L mutations im-
pacted the binding of WT htt, we performed a series of co-IP exper-
iments on HEK293T cells co-transfected with either full length (FL)
GFP-HIP1 WT, K510L, 2M, or 2M + K510L and a 23 polyQ htt con-
struct containing the ﬁrst 900 amino acids of htt. After 24 h cells
were harvested, and a co-IP was performed. As expected, GFP-
HIP1 WT was able to co-IP 23Qhtt-myc (Fig. 2A, lane 3). We found
that both GFP-HIP1 K510L and 2M constructs were able to co-IP a
similar level of the 23Qhtt-myc construct (compare lanes 4,5 with
lane 3; Fig. 2A). In contrast, the intensity of the band from the GFP-
HIP1 2M + K510L co-IP experiment (lane 6) was very strong. One
possible explanation is that there is increased interaction between
Fig. 1. Point mutations at charged interface residues alter apparent stability of HIP1. (A) HIP1 coiled-coil showing residues at a- and d-positions (model PDB code: 2NO2
generated using PyMOL). Asterisks indicate mutations. K510 is colored blue in the opened part of 2NO2. (B–E) Far-UV circular dichroism of HIP1 h 371–647 WT (B) K510L (C)
2M (D) and 2M + K510L CD data were collected from 300 to 190 nm at 5C intervals from 5C to 80C (data plotted beginning at 250 nm). The dashed line represents 40C. (F)
Thermal stability CD proﬁles at 222 nm.
3032 S.N. Fontaine et al. / FEBS Letters 586 (2012) 3030–303623Qhtt-myc construct and GFP-HIP1 2M + K510L. To determine if
the enhanced coIP was due to a combination effect speciﬁc toK510, we repeated the co-IP on a different triple mutant, where
N489 (the previous polar a-position) was mutated to leucine on
Fig. 2. Aggregation of FL HIP1 2M + K510L causes enhanced htt pulldown. (A) Co-IP of GFP-HIP1 constructs co-transfected with 23Qhtt-myc after 24 h transfection. All blots
were balanced for protein load. Data are representative of ﬁve independent co-IP experiments. (B) Confocal microscopy of HEK293T and SH-SY5Y cells transfected with
pEGFP-C2 vector only, GFP-HIP1 FL WT and mutations 18h post-transfection. (C) HEK293T transfected with pEGFP-C2 vector only, GFP-HIP1 FL WT and mutations 6 h post-
transfection. (D) HEK293T transfected with pCDNA3.1-HIP1 FL WT or 2M + K510L after 18 h. Nuclei are counterstained blue in merged image. Arrows indicate aggregated
GFP-HIP1. Scale bar is 10 lm. 75 cells over 5 independent transfections were analyzed. (E) Plot of dynamic light scattering data: mean particle size of HIP1482–586 WT,
K510L, 2M and 2M + K510L. Data shown are mean ± SD (n = 3 ⁄⁄p60.01).
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mutation did not produce an exaggerated htt precipitation, indicat-
ing the effect was speciﬁc to HIP1 2M + K510L.
To determine if subcellular localization could explain the co-IP
results, we performed confocal microscopy experiments using
GFP-HIP1 mutant constructs transfected into HEK293T cells. To
compare the distribution pattern in a human neuronal cell, the
experiment was also performed in SH-SY5Y cells. At 18 h, GFP-
HIP1 WT was overexpressed in the cytosol and at the membrane
but is non-nuclear, which agrees with previously published obser-
vations [10]. GFP-HIP1 2M and GFP-HIP1 K510L exhibited expres-
sion patterns that were similar to GFP-HIP1 WT (Fig. 2B). In
contrast, a proportion of GFP-HIP1 2M + K510L cells (30–40% of
the total population) contained bright, cytoplasmic GFP-positive
puncta (see arrows), indicating the accumulation of amorphous
HIP1 protein aggregates. The size of aggregates ranged from a
few nm to lm in diameter, and the effect was exaggerated at
24 h, when the proportion of cells with aggregated HIP1 increased
to 50%. By 48 h, we observed that nearly all of the GFP-HIP1
2M + K510L expressing cells were laden with aggregates (datanot shown). We point out that GFP-HIP1 2M + N489L-expressing
cells also had aggregates. However, in this case a smaller propor-
tion of cells had aggregated HIP1, and the aggregates also tended
to be smaller in diameter. To verify that the aggregation was not
due to differential protein expression, we performed ﬂow cytome-
try experiments to quantify the amount of GFP ﬂuorescence in
each cell. We found no signiﬁcant difference between WT and
GFP-HIP1 K510L, 2M or 2M + K510L (see Supplementary ﬁg. S1).
To investigate the kinetics of aggregate formation, we analyzed
GFP-HIP1 constructs at 6 h post-transfection (Fig. 2C). Even at this
early time point, both triple mutants GFP-HIP1 2M + K510L and
2M + N489L-expressing cells contained aggregates (see arrows).
In contrast, aggregates were not detected in cells overexpressing
GFP-HIP1 WT, K510L, or 2M. This suggests aggregation is a direct
effect of the triple mutation on structure.
To rule out the possibility that the aggregation effect was due to
the presence of the GFP tag, cells were transfected with either
pCDNA3.1-HIP1(FL)WT or 2M + K510L and visualized after 18 h
using a HIP1 antibody. Aggregates (arrows) were only present in
the cells overexpressing HIP1 2M + K510L (Fig. 2D). This is an
Fig. 3. Overexpression of HIP1 2M + K510L decreases cell viability. (A) MTS viability assay of HEK293T cells overexpressing vector control, HIP1 WT, 2M and 2M + K510L at
12, 18, 24 and 48 h (n=12). (B) MTS data of N2a cells overexpressing HIP1 WT, 2M and 2M + K510L at 12, 18, 24 and 48 h (n = 6). Error bars are SEM, n=6. (C) Flow cytometry
scatter plot of only cells overexpressing GFP-HIP1 WT (top) and 2M + K510L (bottom). (D) Quantiﬁcation of ﬂow cytometry results of Annexin V/ 7-AAD staining 18 h post-
transfection (error bars are SEM, n = 6, ⁄p60.05, ⁄⁄p60.01; ⁄⁄⁄p60.001). (E) Cells overexpressing GFP-HIP1 WT (left) verses 2M + K510L (right) 12 h post transfection (merged
ﬂuorescence and DIC image, top; DIC alone, bottom). Arrows indicate membrane blebs in 2M + K510L-expressing cells only.
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but is the result of mutations in the opened region of the HIP1 CC.
To evaluate if the pro-aggregation property in Fig. 2 was due to
the high level of overexpression in cells, we performed dynamic
light scattering (DLS) experiments on short HIP1 CC constructs that
had none, one, two, or all three mutations. The bar graph in Fig. 2E
summarizes the DLS data on recombinant HIP1468-547 WT,
K510L, 2M, and 2M + K510L. The DLS experiments indicated there
were a mixed population of different sizes (polydisperse) in everysample measured. According to DLS, the mean particle size of HIP1
WT and 2M were similar (8.2 ± 1.2 nm and 7.3 ± 1.9 nm, respec-
tively). On the other hand, both HIP1 2M + K510L and K510L con-
structs produced particle sizes that were signiﬁcantly larger, with
an average size of 205.5 ± 30.5 nm and 232.3 ± 41.8 nm, respec-
tively (⁄⁄p > 0.01). To characterize the aggregates caused by HIP1
2M + K510L, we performed negatively stained transmission
electron microscopy on recombinant HIP1h 2M + K510L. We saw
disordered aggregates and not ordered oligomers or protoﬁbrils
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region of the HIP1 CC is sensitive to theoretically favorable muta-
tions in the interface of a coiled-coil protein. We cannot deﬁnitely
explain the enhanced co-IP of htt with HIP1 2M + K510L, but at this
point it is possible that it is due to an aggregation-driven mass
action effect. This possibility is supported by strong co-localization
of the 23Qmyc-htt fragment with HIP1 2M + K510L aggregates when
these constructs are co-overexpressed in cells (data not shown).
3.3. HIP1 2M + K510L aggregates are toxic to cells
Because HIP1 is known to be pro-apoptotic [11–14], we wanted
to study if the non-aggregating HIP1 mutants have any effect on
HIP1 pro-apoptotic activity. In addition, we wanted to determine
if the observed HIP1 2M + K510L or 2M + N489L aggregates had a
deleterious impact on cells. To address this question, we ﬁrst per-
formed MTS assays on a variety of neuronal and non-neuronal cells
transfected with GFP-HIP1 WT, 2M or 2M + K510L constructs to
assess metabolic viability (Fig. 3A,B). In HEK293T cells, overexpres-
sion of GFP-HIP1WT caused signiﬁcant loss of viability compared to
vector control at 24 h (⁄⁄p < 0.01) and 48 h (⁄⁄⁄p < 0.001) in
agreement with earlier reports [12]. However, as early as 12 h
post-transfection, GFP-HIP1 2M + K510L-expressing cells were
signiﬁcantly (⁄⁄⁄p < 0.001) less viable than WT or 2M expressing
cells. The signiﬁcant loss of cell viability in 2M + K510L expressing
cells was clearly evident at each time point (12, 18, 24 and 48 h)
tested. However, there was no signiﬁcant difference between
GFP-HIP1 WT and 2M overexpressing cells (Fig. 3A).
Next we assessed the impact of GFP-HIP1 2M + K510L in N2a
cells. This neuronal line produced better transfection efﬁciency in
our hands than SH-SY5Y cells, making it more amenable for our
studies. The data show the viability of GFP-HIP1 2M overexpress-
ing cells was similar to those expressing GFP-HIP1 WT at both
18 h and 24 h. However, cells overexpressing GFP-HIP1
2M + K510L (see Fig. 3B) were signiﬁcantly less viable compared
to those expressing WT at 12 h (⁄p < 0.05), WT (⁄⁄p < 0.01) and
2M (⁄p < 0.05) at 18 h, or WT and 2M at 24 h (⁄⁄p < 0.01). Appar-
ently, the HIP1 2M + K510L cell death phenotype is universal (see
also Supplementary Fig. S1). In our hands, the extent of cell death
depended on the cell line, which could be due to differences in
transfection efﬁciency between cell lines that alter the overall
amount of HIP1 overexpressed.
We next explored whether apoptosis was involved in the HIP1
2M + K510L-induced decrease in cell viability. Flow cytometry
analysis was performed on HEK293T cells expressing GFP-HIP1
constructs 18 h post-transfection. Since only those cells expressing
GFP (and therefore HIP1) were analyzed, ﬂow cytometry yielded a
more sensitive measurement of apoptotic cell death than the MTS
assays. Representative scatter plots of GFP-HIP1 WT and
2M + K510L (Fig. 3C) show the different populations of living,
necrotic, and apoptotic cells. The ﬂow cytometry data indicate
cells overexpressing GFP-HIP1 2M + K510L have signiﬁcantly
(⁄⁄⁄p 6 0.001) increased proportions of late apoptotic (AnnexinV/
7AAD-positive, upper right quadrant) and necrotic (7AAD-positive
only, upper left quadrant) populations compared to cells over-
expressing either GFP-HIP1 WT, K510L, 2M or 2M + N489L
(quantiﬁcation shown in Fig. 3D). There is not a statistically
signiﬁcant difference in the percentage of cells staining for early
apoptosis between WT and any mutant. This could be the case if
2M + K510L-expressing cells undergo apoptosis earlier than WT
cells. Consistent with earlier apoptosis, cells expressing GFP-HIP1
2M + K510L exhibited membrane blebbing 12 h post-transfection
where GFP-HIP1 WT cells did not (Fig. 3E). Together, these data
suggest that cells expressing GFP-HIP1 2M + K510L die more rap-
idly and involves necrotic and apoptotic pathways. Based on the
confocal microscopy and DLS results, the signiﬁcant loss of viabilityof HIP1 2M + K510L expressing cells can be correlated to the aggre-
gates caused by the seemingly favorable replacement of charged/
polar residues mutations in the open region of the HIP1 CC.
Inappropriate protein aggregates are present in over 40 differ-
ent human diseases, including neurodegenerative and cardiac con-
ditions, and are thought to mediate the pathology of these
diseases. The most damaging of these protein aggregates are small
amorphous aggregates associated with numerous deleterious ef-
fects that often lead to cell death [15–20]. The cytoplasmic aggre-
gates in HIP1 2M + K510L overexpressing cells together with the
DLS data indicate FL HIP1 2M + K510L exists as disordered particles
with a signiﬁcantly larger diameter than WT or 2M. This may ex-
plain why HIP1 2M + K510L expressing cells had decreased overall
metabolic viability as well as increased late apoptotic and necrotic
cell populations compared to GFP-HIP1 WT, K510L, or 2M express-
ing cells. Although GFP-HIP1 2M + N489L also formed aggregates,
these were smaller and present in a fewer number of cells than
GFP-HIP1 2M + K510L, which could explain why they did not pro-
voke a similar toxic effect.
Recently, it has been shown that speciﬁc mutations that in-
crease the coiled-coil propensity of Q/N rich yeast prions and polyQ
proteins have the effect of increasing their aggregation properties
and cellular toxicity [21]. Replacement of charged/polar residues
at a- and d- positions in the interface of HIP1 would increase the
coiled-coil propensity of the protein because they occupy positions
that are typically reserved for hydrophobic residues. Therefore the
HIP1 2M + K510L aggregation could be due to increased CC propen-
sity of the protein, which then results in increased aggregation. The
sum of our data presented here suggests that the location of the
third mutation, in this case K510L, modulates the aggregation pro-
pensity and overall toxic effect on cells. Our results indicate this re-
gion of the HIP1 CC domain is sensitive to stabilizing mutations,
suggesting the charged residues in the interface of the HIP1
coiled-coil domain are essential for its normal function. This infor-
mation may yield new insights into understanding the relationship
between HIP1 and htt in Huntington’s disease.
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